What indication should be listed on a pelvic ultrasound request for a patient with heavy, painful periods?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pelvic Ultrasound Indication for Heavy Painful Periods

Write "abnormal uterine bleeding" as the indication on the pelvic ultrasound requisition for a patient with heavy, painful periods.

Recommended Imaging Study

The American College of Radiology (ACR) establishes that combined transabdominal and transvaginal ultrasound of the pelvis with Doppler is the most appropriate initial imaging study for patients presenting with abnormal uterine bleeding 1. This is the standard first-line imaging approach regardless of whether the patient is premenopausal or postmenopausal 2.

Why "Abnormal Uterine Bleeding" is the Correct Indication

  • Heavy, painful periods fall under the clinical umbrella term "abnormal uterine bleeding" (AUB), which is the standardized terminology used in imaging guidelines and appropriateness criteria 1.

  • Using this specific indication ensures the radiologist understands the clinical context and performs the appropriate comprehensive evaluation 1.

  • The term "abnormal uterine bleeding" triggers the radiologist to assess for all relevant structural pathologies including polyps, adenomyosis, leiomyomas (fibroids), endometrial hyperplasia, and malignancy 2.

What the Ultrasound Will Evaluate

The transvaginal ultrasound component is essential because it provides high-resolution images of pelvic organs and can diagnose:

  • Structural causes: Endometrial polyps, submucosal fibroids, adenomyosis, and uterine malformations 2
  • Endometrial assessment: Thickness and texture to evaluate for hyperplasia or malignancy 1
  • Ovarian pathology: Ovarian cysts, endometriomas, or masses that may contribute to symptoms 2
  • Signs of endometriosis: Including endometriomas and deep infiltrating disease, which commonly presents with painful periods 3

Common Pitfall to Avoid

Do not write vague indications like "pelvic pain" or "menorrhagia" alone. While these describe the symptoms, "abnormal uterine bleeding" is the comprehensive diagnostic category that directs appropriate imaging protocols and ensures the radiologist evaluates all potential etiologies 1. The ACR Appropriateness Criteria specifically address "abnormal uterine bleeding" as the clinical scenario requiring this imaging approach 1.

If Initial Ultrasound is Inconclusive

Should the uterus be incompletely visualized on the initial ultrasound, MRI of the pelvis without and with contrast becomes the next appropriate study 1. If a polyp is suspected on the original ultrasound, sonohysterography (saline infusion sonography) can be performed to better characterize focal endometrial abnormalities 1.

References

Guideline

acr appropriateness criteria® abnormal uterine bleeding.

Journal of the American College of Radiology, 2020

Research

Transvaginal Ultrasound for the Diagnosis of Abnormal Uterine Bleeding.

Clinical obstetrics and gynecology, 2017

Research

Sonographic Evaluation for Endometriosis in Routine Pelvic Ultrasound.

Journal of minimally invasive gynecology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.